Eli Lilly Shares Rise Premarket on Late-Stage Weight Loss Trial Success – WSJ

1. Eli Lilly Shares Rise Premarket on Late-Stage Weight Loss Trial Success  WSJ
2. Triple-action diabetes jab shown to reduce blood sugar and body weight  The Guardian
3. Retatrutide Data Show Dramatic Weight Loss, Other Benefits  Medscape
4. Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefits  Reuters
5. Lilly’s 30% Weight Loss Sets High Bar for Obesity Drug Race  Bloomberg.com

source